AtaiBeckley Inc.
DelistedCIK 2081043fmd_1M1C453N5MTCCSBD2C5A57VCRAManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2024 to Jun 30, 2026, 6 periods
| Line item | FY2024 | FY2025 |
|---|---|---|
| Total revenues | 0 | 4 |
| Research and development | 1 | 53 |
| Compensation and benefits | 1 | 0 |
| Total operating expenses | 103 | 648 |
| Operating income | (103) | (644) |
| Interest expense | 3 | 1 |
| Interest and investment income | 1 | 1 |
| Other non-operating income (expense) | (46) | (16) |
| Income before taxes | (148) | (660) |
| Income tax expense | (0) | 0 |
| Net income from continuing operations | (148) | (660) |
| Net income | (149) | (660) |
| Net income to common shareholders | (149) | (660) |